TherapeuticsMD Files 2024 Annual Report Amendment
Ticker: TXMD · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 25743
Sentiment: neutral
Topics: amendment, annual-report, pharmaceutical
TL;DR
TherapeuticsMD filed its 2024 10-K amendment. Check for updates.
AI Summary
TherapeuticsMD, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The filing, submitted on April 30, 2025, provides updated information regarding the company's operations and financial status. TherapeuticsMD, Inc. is incorporated in Nevada and operates in the pharmaceutical preparations industry.
Why It Matters
This amendment provides updated disclosures for the fiscal year 2024, which could contain material information for investors regarding the company's financial health and strategic direction.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, TherapeuticsMD faces inherent risks related to drug development, regulatory approvals, and market competition, which are often detailed in 10-K filings.
Key Numbers
- 2024 — Fiscal Year End (The annual report covers the period ending December 31, 2024.)
- 001-00100 — Commission File Number (This is the SEC's file number for TherapeuticsMD, Inc.)
Key Players & Entities
- TherapeuticsMD, Inc. (company) — Registrant
- 2024 (date) — Fiscal year end
- April 30, 2025 (date) — Filing date
- Nevada (location) — State of incorporation
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific information is being amended in this 10-K/A filing?
The filing is an amendment to the annual report for the fiscal year ended December 31, 2024, but the specific details of the amendments are not provided in this header information.
When was the original 10-K filed?
The filing date of this amendment is April 30, 2025, indicating the original 10-K was likely filed around that time or earlier, with this being an update.
What is TherapeuticsMD, Inc.'s primary business sector?
TherapeuticsMD, Inc. operates in the Pharmaceutical Preparations sector, with a Standard Industrial Classification code of 2834.
In which state is TherapeuticsMD, Inc. incorporated?
TherapeuticsMD, Inc. is incorporated in Nevada.
What is the company's business address?
The company's business address is 951 Yamato Road, Suite 220, Boca Raton, Florida, 33431.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding TherapeuticsMD, Inc. (TXMD).